雜志介紹

Clinical Lymphoma Myeloma & Leukemia雜志介紹

《Clinical Lymphoma Myeloma & Leukemia》是一本以English為主的未開放獲取國際優秀期刊，中文名稱臨床淋巴瘤骨髓瘤和白血病，本刊主要出版、報道醫學-HEMATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.7，最新CiteScore 指數為2.7。

本刊近期中國學者發表的論文主要有：

• Correlation of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with susceptibility and prognosis for multiple myemola

  Author: Hongbo Wu, Ting Huang, Zhifeng Ye, Xiaoqing Fu, Keke Hu, Xuefei Yang

• Study on the prognostic value of aberrant antigen in patients with acute B lymphocytic leukemia

  Author: Jun Liu, Xu Tan, Ying-Ying Ma, Yao Liu, Li Gao, Lei Gao, PeiYang Kong, Xian-Gui Peng, Xi Zhang, Cheng Zhang

• Role of p15(INK4B) methylation in patients with myelodysplastic syndromes: a systematic meta-analysis

  Author: Fang Ye, Ningning Li

• Prognostic Value of 1q21 Gain in Multiple Myeloma

  Author: Dangui Chen, Di Zhou, Jingyan Xu, Rongfu Zhou, Jian Ouyang, Bing Chen

英文介紹

Clinical Lymphoma Myeloma & Leukemia雜志英文介紹

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.